Correlation between nasal eosinophilic inflammation and bronchial reactivity to methacholine in allergic children sensitized to house dust mites (HDM) Source: Eur Respir J 2002; 20: Suppl. 38, 172s Year: 2002
The association of adult bronchial responsiveness with IgE sensitisation and exposure to cat and house dust mite allergen Source: Eur Respir J 2006; 28: Suppl. 50, 145s Year: 2006
Allergen exposure in nondog and nonhouse dust mite sensitized atopic asthmatic subjects; effect on bronchial reactivity Source: Eur Respir J 2001; 18: Suppl. 33, 482s Year: 2001
OPURIT: O malizumab-p rotected u ltra r ush s pecific i mmunotherapy in severe asthmatic patients with house dust mite allergy Source: Annual Congress 2011 - Allergen immunotherapy and anti-immunoglobulin E Year: 2011
Sensitisation to house dust mite: its association with bronchial hyperresponsiveness and lung function in asthmatic children Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma Year: 2009
Clinical efficiency of sublingual and subcutaneous allergenspecific immunotherapy with household dust mite allergen in patients with persistent allergic rhinitis Source: Eur Respir J 2006; 28: Suppl. 50, 438s Year: 2006
Safety of subcutaneous immunotherapy with standardized extracts of house dust mite in allergic asthmatic subjects Source: Eur Respir J 2002; 20: Suppl. 38, 57s Year: 2002
Exposure to higher levels of house dust mite allergen and endotoxin is not associated with respiratory symptoms and severity of AHR in older asthmatics Source: Eur Respir J 2002; 20: Suppl. 38, 454s Year: 2002
Is nasal provocation test evaluated by rhinomanometry necessary in diagnosis of nasal allergy to house dust mite? Source: Eur Respir J 2005; 26: Suppl. 49, 400s Year: 2005
Local coagulation activation following bronchial instillation of house dust mite allergen (HDM) and HDM/Lipopolysaccharide (LPS) in mild asthmatics Source: Annual Congress 2012 - Different ways to phenotype asthma Year: 2012
Importance of large particle in bronchial challenge test in mite allergic asthmatics Source: Eur Respir J 2004; 24: Suppl. 48, 588s Year: 2004
Local and systemic inflammatory responses following bronchial instillation of house dust mite allergen (HDM) and HDM/lipopolysaccharide (LPS) in mild asthmatics Source: Annual Congress 2011 - Mechanisms of allergic inflammation of the airways Year: 2011
Diagnostic utility of serum periostin for house dust mite sublingual immunotherapy response in allergic rhinitis Source: Virtual Congress 2021 – Asthma and COPD meets COVID-19: new diagnostic tools and results from clinical trials Year: 2021
Levels of house dust mites (HDM) in homes of patients with bronchial asthma (BA) and the airway inflammation Source: Eur Respir J 2001; 18: Suppl. 33, 281s Year: 2001
Mite and cockroach allergen levels in the dust of dwellings of asthmatics and controls in the reunion island Source: Eur Respir J 2003; 22: Suppl. 45, 302s Year: 2003
House dust mite sublingual immunotherapy reduces type 2 biomarkers in allergic asthma Source: Virtual Congress 2020 – Management of allergy, asthma and COPD Year: 2020
Low exposure to inhaled formaldehyde: effect on allergen bronchial response in asthmatics sensitized to mite Source: Eur Respir J 2006; 28: Suppl. 50, 592s Year: 2006
Exhaled NO in steroid naive house dust mite allergic asthmatics Source: Eur Respir J 2007; 30: Suppl. 51, 617s Year: 2007
The effect of montelukast during allergen sensitization period in house dust mite mouse model Source: International Congress 2017 – "Alarming" immunological patterns in asthma Year: 2017
House dust mite allergens may induce ASM remodeling/hyperplasia by reducing C/EBPα levels Source: Annual Congress 2007 - New mechanisms in the pathogenesis of asthma and allergy Year: 2007